border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


    • Product Description
  • Once a report has been filed with the SEC it will be available on the website.


    • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this SB-2/A on 11/12/1997.
    Click on link to view section or document
    1. Entire Document including Exhibit(s)
    2. SB-2/A
    PAGE: 1 - SECURITIES AND EXCHANGE COMMISSION
    PAGE: 2 -
    PAGE: 3 - FLEMINGTON PHARMACEUTICAL CORPORATION
    PAGE: 4 - PROSPECTUS [LOGO]
    PAGE: 5 -
    PAGE: 6 - SPECIAL STANDARDS FOR SECURITIES SOLD IN CALIFORNIA
    PAGE: 7 -
    PAGE: 8 - PROSPECTUS SUMMARY
    PAGE: 9 -
    PAGE: 10 -
    PAGE: 11 - SUMMARY FINANCIAL DATA
    PAGE: 12 - RISK FACTORS
    PAGE: 13 -
    PAGE: 14 -
    PAGE: 15 -
    PAGE: 16 -
    PAGE: 17 -
    PAGE: 18 -
    PAGE: 19 -
    PAGE: 20 -
    PAGE: 21 -
    PAGE: 22 -
    PAGE: 23 -
    PAGE: 24 - Section 15(b)(6) of the Exchange Act, which gives the Commission the authority
    PAGE: 25 -
    PAGE: 26 -
    PAGE: 27 -
    PAGE: 28 -
    PAGE: 29 - USE OF PROCEEDS
    PAGE: 30 -
    PAGE: 31 - DILUTION
    PAGE: 32 - DIVIDEND POLICY
    PAGE: 33 - CAPITALIZATION
    PAGE: 34 - SELECTED FINANCIAL DATA
    PAGE: 35 -
    PAGE: 36 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF
    PAGE: 37 -
    PAGE: 38 -
    PAGE: 39 -
    PAGE: 40 - BUSINESS OF THE COMPANY
    PAGE: 41 -
    PAGE: 42 -
    PAGE: 43 -
    PAGE: 44 -
    PAGE: 45 -
    PAGE: 46 -
    PAGE: 47 -
    PAGE: 48 -
    PAGE: 49 -
    PAGE: 50 -
    PAGE: 51 - MANAGEMENT
    PAGE: 52 -
    PAGE: 53 - SUMMARY COMPENSATION TABLE
    PAGE: 54 - Section 422 of the Internal Revenue Code of 1986, as amended (the "Code") or
    PAGE: 55 -
    PAGE: 56 - PRINCIPAL STOCKHOLDERS
    PAGE: 57 -
    PAGE: 58 - CERTAIN TRANSACTIONS
    PAGE: 59 - DESCRIPTION OF SECURITIES
    PAGE: 60 -
    PAGE: 61 -
    PAGE: 62 -
    PAGE: 63 - SHARES ELIGIBLE FOR FUTURE SALE
    PAGE: 64 -
    PAGE: 65 - UNDERWRITING
    PAGE: 66 -
    PAGE: 67 -
    PAGE: 68 -
    PAGE: 69 -
    PAGE: 70 -
    PAGE: 71 -
    PAGE: 72 - LEGAL MATTERS
    PAGE: 73 - AVAILABLE INFORMATION
    PAGE: 74 - FLEMINGTON PHARMACEUTICAL CORPORATION
    PAGE: 75 - INDEPENDENT AUDITORS' REPORT
    PAGE: 76 - BALANCE SHEET
    PAGE: 77 - FLEMINGTON PHARMACEUTICAL CORPORATION
    PAGE: 78 - FLEMINGTON PHARMACEUTICAL CORPORATION
    PAGE: 79 - STATEMENTS OF CASH FLOWS
    PAGE: 80 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 81 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 82 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 83 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 84 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 85 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 86 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 87 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 88 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 89 - NOTES TO FINANCIAL STATEMENTS
    PAGE: 90 - TABLE OF CONTENTS
    PAGE: 91 - PROSPECTUS
    PAGE: 92 - Item 24. Indemnification of Directors and Officers.
    PAGE: 93 - Item 25. Other Expenses of Issuance and Distribution.
    PAGE: 94 - Item 26. Recent Sales of Unregistered Securities.
    PAGE: 95 - Item 28. Undertakings.
    PAGE: 96 - Item 24, or otherwise, the Registrant has been advised that in the opinion of
    PAGE: 97 - CONSENT OF INDEPENDENT AUDITORS
    PAGE: 98 - SIGNATURES AND POWERS OF ATTORNEY
    PAGE: 99 - SIGNATURES




    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer